Analysis reveals limits in body composition measurements across devices, suggesting caution in clinical settings.
BIA and 3DS exhibited acceptable precision for most whole-body 2C outcomes, yet measurements were not interchangeable with DXA at the individual level. These findings caution against applying cross-device normative data or clinical cut-points and underscore the limitations of substituting BIA or 3DS for DXA in general practice.
No takes yet. Share an insight, caveat, or question.
Oliver et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: